According to MeiraGTx's latest financial reports the company's current revenue (TTM ) is ยฃ25.83 Million. In 2024 the company made a revenue of ยฃ26.51 Million an increase over the revenue in the year 2023 that were of ยฃ11 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | ยฃ26.91 M | 1.49% |
2024 | ยฃ26.51 M | 141.03% |
2023 | ยฃ11 M | -16.39% |
2022 | ยฃ13.15 M | -52.89% |
2021 | ยฃ27.93 M | 144.61% |
2020 | ยฃ11.41 M | 12.65% |
2019 | ยฃ10.13 M | |
2018 | N/A | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Novocure
NVCR | ยฃ0.46 B | 1,701.64% | Jersey |
![]() Novavax NVAX | ยฃ0.90 B | 3,419.88% | ๐บ๐ธ USA |
![]() Organovo ONVO | ยฃ0.1 M | -99.58% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | ยฃ16.35 M | -36.71% | ๐ฌ๐ง UK |